dx 8951 has been researched along with sufentanil in 1 studies
| Studies (dx 8951) | Trials (dx 8951) | Recent Studies (post-2010) (dx 8951) | Studies (sufentanil) | Trials (sufentanil) | Recent Studies (post-2010) (sufentanil) |
|---|---|---|---|---|---|
| 73 | 18 | 15 | 2,156 | 956 | 678 |
| Protein | Taxonomy | dx 8951 (IC50) | sufentanil (IC50) |
|---|---|---|---|
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 4.5 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0023 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0014 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0023 | |
| Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | 2.077 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
1 other study(ies) available for dx 8951 and sufentanil
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |